FCPM III SERVICES B.V.
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.8%; sector active share 90.9% against the combined 13F book's sector weights.
Over time 11 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
10 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $749,575,144 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNew Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | 4,053,775 | $28,781,802 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 8,490,353 | $287,738,062 | 38.39% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 3,226,400 | $115,634,176 | 15.43% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 3,848,256 | $85,469,765 | 11.40% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 4,117,354 | $75,800,487 | 10.11% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
Held | 2,441,000 | $63,490,410 | 8.47% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Held | 2,808,368 | $31,088,633 | 4.15% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 1,677,852 | $30,201,336 | 4.03% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
NEW | 4,053,775 | $28,781,802 | 3.84% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 9,632,561 | $16,664,330 | 2.22% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Held | 3,468,430 | $14,706,143 | 1.96% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.